- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: 92.19%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | -0.06 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (9) | 0.47 | -9.62 | 0.60 | 71.43 | 0.00 | 0 | 127.66 | 89.67 | 0.00 | 0 | 127.66 | 89.67 |
| 2021 (8) | 0.52 | 0 | 0.35 | 0 | 0.00 | 0 | 67.31 | 0 | 0.00 | 0 | 67.31 | 0 |
| 2020 (7) | -0.90 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2019 (6) | -0.13 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2018 (5) | 0.82 | 0 | 0.73 | 0 | 0.00 | 0 | 89.02 | 0 | 0.00 | 0 | 89.02 | 0 |
| 2017 (4) | -0.81 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | 1.18 | 96.67 | 1.00 | 0.0 | 0.00 | 0 | 84.75 | -49.15 | 0.00 | 0 | 84.75 | -49.15 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | -0.22 | 46.34 | -46.67 | -0.19 | 59.57 | 26.92 | -0.63 | -53.66 | -493.75 |
| 24Q2 (19) | -0.41 | 0 | -115.79 | -0.47 | -422.22 | -62.07 | -0.41 | 0 | -232.26 |
| 24Q1 (18) | 0.00 | 100.0 | -100.0 | -0.09 | -28.57 | -117.65 | 0.00 | 100.0 | -100.0 |
| 23Q4 (17) | -0.22 | -46.67 | -215.79 | -0.07 | 73.08 | -122.58 | -0.06 | -137.5 | -112.77 |
| 23Q3 (16) | -0.15 | 21.05 | -236.36 | -0.26 | 10.34 | -333.33 | 0.16 | -48.39 | -42.86 |
| 23Q2 (15) | -0.19 | -138.0 | -272.73 | -0.29 | -156.86 | -514.29 | 0.31 | -38.0 | 82.35 |
| 23Q1 (14) | 0.50 | 163.16 | 733.33 | 0.51 | 64.52 | 5000.0 | 0.50 | 6.38 | 733.33 |
| 22Q4 (13) | 0.19 | 72.73 | 46.15 | 0.31 | 616.67 | 93.75 | 0.47 | 67.86 | -9.62 |
| 22Q3 (12) | 0.11 | 0.0 | 450.0 | -0.06 | -185.71 | 0 | 0.28 | 64.71 | -28.21 |
| 22Q2 (11) | 0.11 | 83.33 | 1000.0 | 0.07 | 600.0 | 75.0 | 0.17 | 183.33 | -54.05 |
| 22Q1 (10) | 0.06 | -53.85 | -83.33 | 0.01 | -93.75 | -96.77 | 0.06 | -88.46 | -83.33 |
| 21Q4 (9) | 0.13 | 550.0 | -23.53 | 0.16 | 0 | 166.67 | 0.52 | 33.33 | 157.78 |
| 21Q3 (8) | 0.02 | 100.0 | -84.62 | 0.00 | -100.0 | -100.0 | 0.39 | 5.41 | 136.11 |
| 21Q2 (7) | 0.01 | -97.22 | 101.72 | 0.04 | -87.1 | 105.63 | 0.37 | 2.78 | 130.58 |
| 21Q1 (6) | 0.36 | 111.76 | 157.14 | 0.31 | 416.67 | 147.69 | 0.36 | 140.0 | 157.14 |
| 20Q4 (5) | 0.17 | 30.77 | 270.0 | 0.06 | -40.0 | 300.0 | -0.90 | 16.67 | -592.31 |
| 20Q3 (4) | 0.13 | 122.41 | 0.0 | 0.10 | 114.08 | 0.0 | -1.08 | 10.74 | 0.0 |
| 20Q2 (3) | -0.58 | 7.94 | 0.0 | -0.71 | -9.23 | 0.0 | -1.21 | -92.06 | 0.0 |
| 20Q1 (2) | -0.63 | -530.0 | 0.0 | -0.65 | -2066.67 | 0.0 | -0.63 | -384.62 | 0.0 |
| 19Q4 (1) | -0.10 | 0.0 | 0.0 | -0.03 | 0.0 | 0.0 | -0.13 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 1.29 | -4.67 | 19.31 | 11.66 | -8.44 | 3.58 | N/A | - | ||
| 2024/10 | 1.35 | 42.9 | 22.28 | 10.37 | -11.01 | 3.33 | N/A | - | ||
| 2024/9 | 0.95 | -8.63 | -2.87 | 9.02 | -14.5 | 3.31 | 1.82 | - | ||
| 2024/8 | 1.03 | -21.95 | 11.62 | 8.07 | -15.68 | 3.22 | 1.86 | - | ||
| 2024/7 | 1.33 | 54.4 | 58.04 | 7.04 | -18.61 | 3.28 | 1.83 | 大型專案挹注營收 | ||
| 2024/6 | 0.86 | -21.53 | -18.37 | 5.71 | -26.84 | 2.84 | 2.09 | - | ||
| 2024/5 | 1.09 | 22.92 | 28.95 | 4.86 | -28.16 | 3.14 | 1.89 | - | ||
| 2024/4 | 0.89 | -22.68 | -28.44 | 3.76 | -36.36 | 3.03 | 1.96 | - | ||
| 2024/3 | 1.15 | 16.89 | -49.79 | 2.87 | -38.47 | 2.87 | 1.84 | - | ||
| 2024/2 | 0.98 | 33.97 | -24.11 | 1.72 | -27.53 | 2.58 | 2.05 | - | ||
| 2024/1 | 0.74 | -14.64 | -31.66 | 0.74 | -31.66 | 2.68 | 1.97 | - | ||
| 2023/12 | 0.86 | -20.2 | -29.11 | 13.6 | 8.07 | 3.05 | 1.73 | - | ||
| 2023/11 | 1.08 | -2.29 | -22.63 | 12.73 | 12.05 | 3.16 | 1.67 | - | ||
| 2023/10 | 1.1 | 13.49 | -7.37 | 11.65 | 16.9 | 3.0 | 1.75 | - | ||
| 2023/9 | 0.97 | 5.0 | -7.15 | 10.55 | 20.2 | 2.74 | 1.8 | - | ||
| 2023/8 | 0.93 | 10.5 | 9.78 | 9.58 | 23.91 | 2.82 | 1.75 | - | ||
| 2023/7 | 0.84 | -20.25 | -22.72 | 8.65 | 25.65 | 2.74 | 1.8 | - | ||
| 2023/6 | 1.05 | 23.95 | -5.77 | 7.81 | 34.7 | 3.14 | 1.42 | - | ||
| 2023/5 | 0.85 | -31.79 | -24.27 | 6.76 | 44.35 | 4.39 | 1.02 | - | ||
| 2023/4 | 1.24 | -45.74 | 46.64 | 5.91 | 65.95 | 4.83 | 0.92 | 大型專案挹注營收 | ||
| 2023/3 | 2.29 | 76.67 | 108.0 | 4.67 | 71.99 | 4.67 | 1.06 | 大型專案挹注營收 | ||
| 2023/2 | 1.3 | 20.64 | 59.57 | 2.37 | 47.34 | 3.59 | 1.38 | 大型專案挹注營收 | ||
| 2023/1 | 1.08 | -11.46 | 34.88 | 1.08 | 34.88 | 3.69 | 1.35 | - | ||
| 2022/12 | 1.22 | -12.9 | 0.46 | 12.58 | -11.34 | 3.8 | 1.47 | - | ||
| 2022/11 | 1.4 | 16.97 | -5.99 | 11.36 | -12.44 | 3.64 | 1.54 | - | ||
| 2022/10 | 1.19 | 13.77 | -15.04 | 9.97 | -13.27 | 3.09 | 1.82 | - | ||
| 2022/9 | 1.05 | 24.15 | -19.48 | 8.78 | -13.02 | 2.98 | 2.09 | - | ||
| 2022/8 | 0.84 | -22.21 | -28.75 | 7.73 | -12.06 | 3.05 | 2.05 | - | ||
| 2022/7 | 1.09 | -2.76 | 2.92 | 6.88 | -9.46 | 3.32 | 1.88 | - | ||
| 2022/6 | 1.12 | -0.38 | -8.73 | 5.8 | -11.46 | 3.09 | 1.98 | - | ||
| 2022/5 | 1.12 | 32.09 | -10.16 | 4.68 | -12.08 | 3.07 | 1.99 | - | ||
| 2022/4 | 0.85 | -23.04 | -2.56 | 3.56 | -12.67 | 2.76 | 2.21 | - | ||
| 2022/3 | 1.1 | 35.54 | -9.43 | 2.71 | -15.41 | 2.71 | 2.25 | - | ||
| 2022/2 | 0.81 | 1.97 | -23.14 | 1.61 | -19.07 | 2.82 | 2.16 | - | ||
| 2022/1 | 0.8 | -34.05 | -14.47 | 0.8 | -14.47 | 3.49 | 1.75 | - | ||
| 2021/12 | 1.21 | -18.5 | 10.91 | 14.19 | 37.65 | 4.1 | 1.4 | - | ||
| 2021/11 | 1.48 | 5.71 | 37.88 | 12.98 | 40.81 | 4.19 | 1.37 | - | ||
| 2021/10 | 1.4 | 7.82 | 41.83 | 11.5 | 41.2 | 3.89 | 1.47 | - | ||
| 2021/9 | 1.3 | 9.86 | 19.76 | 10.09 | 41.11 | 3.54 | 1.8 | - | ||
| 2021/8 | 1.19 | 12.37 | 63.79 | 8.79 | 44.94 | 3.46 | 1.85 | 今年有大型專案挹注營收，且去年同期因新冠肺炎疫情影響。 | ||
| 2021/7 | 1.05 | -13.77 | -10.31 | 7.6 | 42.38 | 3.53 | 1.81 | - | ||
| 2021/6 | 1.22 | -1.93 | 81.3 | 6.55 | 57.26 | 3.34 | 1.51 | 去年同期因新冠肺炎疫情影響，全球各地封城等因素造成營收下滑 | ||
| 2021/5 | 1.25 | 43.26 | 132.01 | 5.33 | 52.62 | 3.34 | 1.52 | 去年同期因新冠肺炎疫情影響全球各地封城等因素營收下滑 | ||
| 2021/4 | 0.87 | -28.46 | 21.0 | 4.08 | 38.16 | 3.15 | 1.61 | - | ||
| 2021/3 | 1.22 | 15.02 | 70.7 | 3.21 | 43.69 | 3.21 | 1.43 | 去年同期因新冠肺炎疫情影響全球各地封城等因素營收下滑。 | ||
| 2021/2 | 1.06 | 13.47 | 18.77 | 1.99 | 31.01 | 3.08 | 1.49 | - | ||
| 2021/1 | 0.93 | -14.48 | 48.36 | 0.93 | 48.36 | 3.1 | 1.48 | - | ||
| 2020/12 | 1.09 | 1.3 | -12.37 | 10.31 | -19.9 | 3.16 | 1.32 | - | ||
| 2020/11 | 1.08 | 8.74 | 10.79 | 9.22 | -20.7 | 3.15 | 1.32 | - | ||
| 2020/10 | 0.99 | -8.95 | -7.2 | 8.14 | -23.57 | 2.8 | 1.49 | - | ||
| 2020/9 | 1.09 | 50.25 | 13.44 | 7.15 | -25.4 | 2.99 | 1.41 | - | ||
| 2020/8 | 0.72 | -38.46 | -35.8 | 6.06 | -29.71 | 2.57 | 1.64 | - | ||
| 2020/7 | 1.18 | 74.29 | -4.01 | 5.34 | -28.8 | 2.39 | 1.76 | - | ||
| 2020/6 | 0.67 | 25.48 | -36.33 | 4.16 | -33.64 | 1.93 | 2.47 | - | ||
| 2020/5 | 0.54 | -25.28 | -64.02 | 3.49 | -33.09 | 1.97 | 2.43 | 受疫情影響,主要國家封城及部份區域無法出貨所致。 | ||
| 2020/4 | 0.72 | 0.91 | -18.61 | 2.95 | -20.66 | 2.32 | 2.06 | - | ||
| 2020/3 | 0.71 | -19.97 | -38.47 | 2.23 | -21.3 | 2.23 | 1.93 | - | ||
| 2020/2 | 0.89 | 41.74 | 35.2 | 1.52 | -9.44 | 2.76 | 1.56 | - | ||
| 2020/1 | 0.63 | -49.49 | -38.31 | 0.63 | -38.31 | 0.0 | N/A | - | ||
| 2019/12 | 1.24 | 28.08 | 15.47 | 12.87 | -17.93 | 0.0 | N/A | - |
